Resistant or Refractory Solid Tumors
1 clinical trials · Condition
◉ Watch Resistant or Refractory Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors (NCT04686383) | Calgent Biotechnology Co., Ltd | 2020-12-29 |
Track Resistant or Refractory Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.